A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy and safety of intravenous Mircera, given as maintenance
treatment for renal anemia in chronic kidney disease patients on dialysis who were previously
receiving iv epoetin. The anticipated time on study treatment is 1-2 years and the target
sample size is 100-500 individuals.